DTX2 and central nervous system cancer: Moreover, among the different pathological types of glioma, the expression of DTX2 was highest in glioblastoma, the most malignant type, slightly lower in astrocytoma, and lower in oligoastrocytoma and oligodendroglioma (Additional file 1: Fig. S1F).